Table 3.

Comparison of CI, FAB, WML, and FHI in the VaD, VCIND, and NCI patients ($\overline{x}$ ± s).

Group	Treatment time	CI	FAB	WML	FHI
VaD (n = 40)	Before treatment	5.92 ± 0.89	11.41 ± 2.34	14.15 ± 3.23	3.43 ± 0.63
	After 6 months of treatment	5.58 ± 0.81	11.57 ± 2.53	9.54 ± 2.35	3.75 ± 0.58
	After 12 months of treatment	5.14 ± 0.69	11.64 ± 2.77	3.63 ± 2.47	3.95 ± 0.29
VCIND (n = 40)	Before treatment	5.28 ± 0.84	11.45 ± 2.44	11.34 ± 3.16	3.55 ± 0.87
	After 6 months of treatment	5.16 ± 0.81	11.53 ± 2.34	7.68 ± 2.33	3.84 ± 0.64
	After 12 months of treatment	5.09 ± 0.78	11.57 ± 2.70	3.55 ± 2.45	4.01 ± 0.46
NCI (n = 40)	Before treatment	5.05 ± 0.88	11.44 ± 2.44	3.10 ± 3.55	4.06 ± 0.35
	After 6 months of treatment	5.03 ± 0.67	11.56 ± 2.83	2.34 ± 2.27	4.07 ± 0.51
	After 12 months of treatment	5.02 ± 0.66	11.63 ± 2.54	2.67 ± 2.68	4.09 ± 0.32
F/P VaD group value		0.758/0.001	0.660/0.014	0.116/0.016	0.855/0.001
F/P VCIND group value		0.431/0.011	0.357/0.006	0.775/0.007	0.465/0.015
F/P NCI group value		0.297/0.024	0.486/0.001	0.248/0.001	0.784/0.020
t/P 6 months treatment group value		0.644/0.001	0.355/0.022	0.351/0.014	0.694/0.010
t/P 12 months treatment group value		0.586/0.014	0.622/0.001	0.896/0.001	0.579/0.001